Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
France
/
Pharmaceuticals & Biotech
/
Euroapi
EAPI
Euroapi
Rising Regulatory And Geopolitical Risks Will Undermine API Profits
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 5 Analysts
Published
12 Aug 25
Updated
16 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
€2.50
24.0% overvalued
intrinsic discount
16 Aug
€3.10
Loading
1Y
-26.0%
7D
4.8%
Author's Valuation
€2.5
24.0% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
€2.5
24.0% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-287m
994m
2019
2021
2023
2025
2027
2028
Revenue €829.4m
Earnings €91.4m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
1.23%
Pharma revenue growth rate
1.05%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
5.98%
Calculation
€91.36m
Earnings '28
x
3.09x
PE Ratio '28
=
€282.71m
Market Cap '28
€282.71m
Market Cap '28
/
95.07m
No. shares '28
=
€2.97
Share Price '28
€2.97
Share Price '28
Discounted to 2025 @ 5.98% p.a.
=
€2.50
Fair Value '25
